QNRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Quoin Pharmaceuticals Ltd (QNRX) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. The lack of positive financial performance, absence of significant trading trends, and no strong technical or proprietary trading signals suggest that holding off on this investment is prudent.
The MACD is positive but contracting, RSI is neutral at 50.781, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 8.852, with resistance at 9.597 and support at 8.107. Overall, the technical indicators do not suggest a strong buy signal.
No recent news or significant positive catalysts identified. Hedge funds and insiders are neutral, and there is no recent congress trading data.
The stock has a low probability of positive movement in the short term, with a 30% chance of a 0.13% increase in the next day, -0.05% in the next week, and -4.5% in the next month. Additionally, the company has poor financial performance with negative EPS and net income.
In Q3 2025, revenue remained at 0 with no YoY growth. Net income improved YoY but remains negative at -$3,948,165. EPS dropped significantly by -58.81% YoY to -6.71. Gross margin is 0, indicating no profitability.
No data on analyst ratings or price target changes is available.
